1. Guilin Sankin (002275): the concept is the most authentic, especially with the U.S. stock market is currently the hottest celator has the most consistent "precision medicine + anti-cancer" concept. Its 100%-owned subsidiary Baofeng Biological has been working in the field of precision medicine for many years, and its core R & D personnel are Chinese Americans from large-scale well-known pharmaceutical companies. Baofeng Bio currently has two anti-cancer R&D programs, the Epiduo program (for the treatment of metastatic colorectal cancer) and the Herceptin program (mainly for the treatment of certain HER-2 positive breast cancers) both of which are best-selling anti-cancer drugs.
2. New Open Source (300109): the fixed-income acquisition of Sanji Biological, Heer Medical and Jingneng Biological 100% equity. Acquisition of companies mainly do genetic testing .
3. Anke Bio (300009): in April 2016, the company intends to 449.88 million yuan to acquire 100% of the shares of Zhongde Meilian. The subject company's business scope includes bioengineering, biochip , genetic engineering antibodies and drugs, etc., belonging to the field of precision medicine.
4. Thousand Mountain Pharmaceutical Machinery (300216): Holding subsidiary Hong Hao gene of individualized medication hypertension gene detection chip is currently growing faster.